Entering text into the input field will update the search result below

Plus Therapeutics, Inc. (PSTV) Q4 2022 Earnings Call Transcript

Feb. 23, 2023 11:07 PM ETPlus Therapeutics, Inc. (PSTV)
SA Transcripts profile picture
SA Transcripts

Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET

Company Participants

Marc Hedrick - President and Chief Executive Officer

Norman LaFrance - Chief Medical Officer

Andrew Sims - Chief Financial Officer

Conference Call Participants

Justin Walsh - Jones Trading

Edward Woo - Ascendiant Capital

Sean Lee - HC Wainwright


Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Fourth Quarter and Full Year 2022 Results Conference Call.

Before we begin, we want to advise you that over the course of the call and question-and-answer session, forward-looking statements will be made regarding events, trends, business prospects and financial performance, which may affect Plus Therapeutics' future operating results and financial position.

All such statements are subject to risks and uncertainties, including the risks and uncertainties described under the Risk Factors section included in Plus Therapeutics' annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission from time-to-time.

Plus Therapeutics advises you to review these risk factors in considering such statements. Plus Therapeutics assumes no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made.

It is now my pleasure to turn the floor over to Dr. Marc Hedrick, Plus Therapeutics' President and Chief Executive Officer. Sir, you may begin.

Marc Hedrick

Thank you, Andrea. Good afternoon everyone, and thank you once again for taking the time to join us today as we provide an overview of recent business highlights and discuss our 2022 fourth quarter financial results. Joining me for the call today is Dr. Norman LaFrance, our Chief Medical Officer and Mr. Andrew Sims, our Chief Financial officer.

I'll begin the call by reviewing 2022 and then Andrew to review our financials and Dr. LaFrance will

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.